Applause Therapeutics (APLS) surged 135.4% to $40.23 on exceptional 90.3 million share volume, while maskless-payment platform MASK rallied 83.1% alongside biotech peer ELAB’s 68.3% gain, signaling a high-risk speculative rally concentrated in micro-cap and healthcare names. Lose
